Get started
uniQure N.V.uniQure N.V.uniQure N.V.

uniQure N.V.

No trades
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.24 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.39 USD
Net income (FY)
‪−239.56 M‬ USD
Revenue (FY)
‪27.12 M‬ USD
Shares float
‪56.77 M‬
Beta (1Y)
0.57

Employees


Employees (FY)
209
Change (1Y)
−271 −56.46%
Revenue / Employee (1Y)
‪129.76 K‬ USD
Net income / Employee (1Y)
‪−1.15 M‬ USD

About uniQure N.V.


Sector
Health Technology
Industry
Biotechnology
CEO
Matthew C. Kapusta
Website
uniqure.com
Headquarters
Amsterdam
Founded
2012
Identifiers
2
ISIN:NL0010696654
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

Check out other big names from the same industry as 0EE0.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


VXF
Vanguard Extended Market ETF
Weight
0.05%
Market value
‪43.61 M‬
USD
XBI
State Street SPDR S&P Biotech ETF
Weight
0.31%
Market value
‪24.80 M‬
USD
VHT
Vanguard Health Care ETF
Weight
0.04%
Market value
‪8.02 M‬
USD
IBB
iShares Biotechnology ETF
Weight
0.09%
Market value
‪7.95 M‬
USD
SCHA
Schwab U.S. Small-Cap ETF
Weight
0.03%
Market value
‪5.76 M‬
USD
JGRO
JPMorgan Active Growth ETF
Weight
0.03%
Market value
‪2.14 M‬
USD
LABU
Direxion Daily S&P Biotech Bull 3X Shares
Weight
0.44%
Market value
‪1.56 M‬
USD
FRTY
Alger Mid Cap 40 ETF
Weight
0.96%
Market value
‪1.17 M‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.10%
Market value
‪875.96 K‬
USD
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.10%
Market value
‪875.96 K‬
USD
KOMP
State Street SPDR S&P Kensho New Economies Composite ETF
Weight
0.03%
Market value
‪708.39 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of 0EE0 is 19.84 USD — it has decreased by −3.37% in the past 24 hours. Watch uniQure N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange uniQure N.V. stocks are traded under the ticker 0EE0.
0EE0 stock has fallen by −9.17% compared to the previous week, the month change is a −24.99% fall, over the last year uniQure N.V. has showed a 30.07% increase.
We've gathered analysts' opinions on uniQure N.V. future price: according to them, 0EE0 price has a max estimate of 95.00 USD and a min estimate of 30.00 USD. Watch 0EE0 chart and read a more detailed uniQure N.V. stock forecast: see what analysts think of uniQure N.V. and suggest that you do with its stocks.
0EE0 reached its all-time high on Jun 21, 2019 with the price of 81.00 USD, and its all-time low was 3.74 USD and was reached on Jul 5, 2024. View more price dynamics on 0EE0 chart.
See other stocks reaching their highest and lowest prices.
0EE0 stock is 3.08% volatile and has beta coefficient of 0.57. Track uniQure N.V. stock price on the chart and check out the list of the most volatile stocks — is uniQure N.V. there?
Today uniQure N.V. has the market capitalization of ‪1.22 B‬, it has decreased by −11.43% over the last week.
Yes, you can track uniQure N.V. financials in yearly and quarterly reports right on TradingView.
uniQure N.V. is going to release the next earnings report on Mar 2, 2026. Keep track of upcoming events with our Earnings Calendar.
0EE0 earnings for the last quarter are −1.38 USD per share, whereas the estimation was −0.90 USD resulting in a −52.86% surprise. The estimated earnings for the next quarter are −0.92 USD per share. See more details about uniQure N.V. earnings.
uniQure N.V. revenue for the last quarter amounts to ‪3.70 M‬ USD, despite the estimated figure of ‪5.79 M‬ USD. In the next quarter, revenue is expected to reach ‪5.29 M‬ USD.
0EE0 net income for the last quarter is ‪−80.53 M‬ USD, while the quarter before that showed ‪−37.72 M‬ USD of net income which accounts for −113.50% change. Track more uniQure N.V. financial stats to get the full picture.
No, 0EE0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 13, 2025, the company has 209 employees. See our rating of the largest employees — is uniQure N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. uniQure N.V. EBITDA is ‪−176.91 M‬ USD, and current EBITDA margin is −632.89%. See more stats in uniQure N.V. financial statements.
Like other stocks, 0EE0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade uniQure N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So uniQure N.V. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating uniQure N.V. stock shows the sell signal. See more of uniQure N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.